Suppliers / Hangzhou Minsheng Binjiang Pharmaceutical

Hangzhou Minsheng Binjiang Pharmaceutical

China Updated 9 July 2026

Hangzhou Minsheng Binjiang Pharmaceutical is a finished-dose manufacturer based in China. It appears in 7 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA and INVIMA (CO).

0
active US DMFs
0
valid CEPs
0
registered plants
7
filings across 2 regulators

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 5 None
INVIMA (CO) 2 None

Limited public record

Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.

Questions about Hangzhou Minsheng Binjiang Pharmaceutical

Does Hangzhou Minsheng Binjiang Pharmaceutical hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Hangzhou Minsheng Binjiang Pharmaceutical. It does have 7 filings with 2 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Where does Hangzhou Minsheng Binjiang Pharmaceutical file?
Filings are on record with US FDA and INVIMA (CO), 7 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Hangzhou Minsheng Binjiang Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability